Clinical translation of carbon nanomaterials: the clinical translation paradox, regulatory barriers, and future pathways
Nanoscale · 2026
DOI: 10.1039/d6nr00596a ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanoscale, 2026. Verfasst von Yalei Guo und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, Department of Head and…. Hauptthemen laut MEDLINE: Translational Research, Biomedical. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 262 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Natural Science Foundation of Sichuan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Carbon nanomaterials face a clinical translation paradox where functional complexity conflicts with regulatory predictability. This review offers a practical roadmap for safer, more controllable, and clinically translatable carbon nanotechnologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University…
- Department of Oromaxillofacial-Head & Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, College of Stomatology, National Center for Stomatology, National Clinical Researc…
- Psychiatric Laboratory and Mental Health Center, the State Key Laboratory of Biotherapy, West China Hospital of Sichuan University, Chengdu 610041, China.
Förderung
- China Postdoctoral Science Foundation
- Natural Science Foundation of Sichuan Province
- National Natural Science Foundation of China
Zitieren
APA
Guo, Y., Liu, Y., Zhao, J., Tao, S., Bao, M., Shi, L., Li, C., Cui, W., & Guo, Z. (2026). Clinical translation of carbon nanomaterials: the clinical translation paradox, regulatory barriers, and future pathways. Nanoscale. https://doi.org/10.1039/d6nr00596a
Vancouver
Guo Y, Liu Y, Zhao J, Tao S, Bao M, Shi L, et al. Clinical translation of carbon nanomaterials: the clinical translation paradox, regulatory barriers, and future pathways. Nanoscale. 2026. doi:10.1039/d6nr00596a
BibTeX
@article{Guo2026,
author = {Guo, Yalei and Liu, Yige and Zhao, Jiahe and Tao, Shihan and Bao, Mingzhe and Shi, Lei and Li, Chunjie and Cui, Weitong and Guo, Zhiyong},
title = {Clinical translation of carbon nanomaterials: the clinical translation paradox, regulatory barriers, and future pathways},
journal = {Nanoscale},
year = {2026},
doi = {10.1039/d6nr00596a}
}
EUVIMED